ANI Pharmaceuticals
ANIP
ANIP
32 hedge funds and large institutions have $25.8M invested in ANI Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
14% more funds holding
Funds holding: 28 → 32 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
32
Holding in Top 10
1
Calls
$9.26M
Puts
$873K
Top Buyers
| 1 | +$1.19M | |
| 2 | +$998K | |
| 3 | +$357K | |
| 4 |
Morgan Stanley
New York
|
+$328K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$266K |
Top Sellers
| 1 | -$890K | |
| 2 | -$189K | |
| 3 | -$4.62K | |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$4K |
| 5 |
Barclays
London,
United Kingdom
|
-$207 |